A Double-Blind, Randomized, Multicenter Study to Evaluate the Safety, Tolerability, and Immunogenicity of V211 Administered Concomitantly Versus Nonconcomitantly With Influenza Virus Vaccine (Inactivated)

Trial Profile

A Double-Blind, Randomized, Multicenter Study to Evaluate the Safety, Tolerability, and Immunogenicity of V211 Administered Concomitantly Versus Nonconcomitantly With Influenza Virus Vaccine (Inactivated)

Completed
Phase of Trial: Phase III

Latest Information Update: 22 Sep 2015

At a glance

  • Drugs Influenza virus vaccine; Varicella zoster virus vaccine live
  • Indications Herpes zoster; Influenza virus infections
  • Focus Pharmacodynamics
  • Most Recent Events

    • 12 Oct 2012 Planned number of patients changed from 540 to 746.
    • 20 May 2009 Actual end date (Mar 2006) added as reported by ClinicalTrials.gov.
    • 24 Oct 2007 Status changed from in progress to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top